Biotechnology companies are cashed up and confident, but believe the government lacks a coherent plan to ensure that their industry prospers.
That’s the view from a survey of 48 companies, which found that 81 per cent expected their business to grow – the most optimistic result in the four years of the survey.
Loading...
Jessica Gardner is Deputy editor - News. She has previously edited the Companies and Markets section. Connect with Jessica on Twitter. Email Jessica at jgardner@afr.com
